Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
SLC26A2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
BBIP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
EIF4G3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SMIM8 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FMR1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CEP68 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NMT2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MAPK1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
UBE2Q1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ERVK3-1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SEPHS1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HIVEP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
METTL4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLF1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
IMPACT - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
KCMF1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ACSL3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
YIPF5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RAB12 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PPP6C - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on